Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate

@article{Derive2014AttenuationOR,
  title={Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate},
  author={Marc Derive and Amir Boufenzer and Sebastien Gibot},
  journal={Anesthesiology},
  year={2014},
  volume={120},
  pages={935–942}
}
Background:The triggering receptor expressed on myeloid cells-1 is an immunoreceptor that amplifies the inflammatory response mediated by toll-like receptors engagement. Triggering receptor expressed on myeloid cells-1 inhibitory peptides such LR12 have been shown to prevent hyperresponsiveness and death in several experimental models of septic shock. Methods:Twelve adult male Cynomolgus (Macaca fascicularis) monkeys exposed to an intravenous bolus of endotoxin (10 &mgr;g/kg) were randomized to… 

Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation

TLDR
A targeted endothelial TREM-1 inhibition is able to dampen cell activation and to confer protection during septic shock in mice, and the use of such cell-specific, ligand- independent T REM-1 inhibitors deserve further investigations during acute or chronic inflammatory disorders.

TREM-1 Modulation Strategies for Sepsis

TLDR
This review encompasses the ligands investigated as activators of TREM-1 thus far and highlights the development and efficacy of novel inhibitors for the treatment of sepsis and septic shock.

Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review

TLDR
Considering the potential of this receptor as a therapeutic target, the present review encompasses the main compounds explored so far in TREM-1 modulation, highlighting and critically discussing its effects and major drawbacks.

Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock

TLDR
It is reported that TREM-1 is expressed and inducible in endothelial cells and plays a direct role in vascular inflammation and dysfunction.

Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

TLDR
A deeper conceptual understanding of the mechanisms associated with pathogenic and/or protective functions of TREM-1 in antiviral immunity is essential to develop novel therapeutic strategies for the control of virus infection by modulating innate immune signaling.

TREM-1 multimerization is essential for its activation on monocytes and neutrophils

TLDR
It is shown that TREM-1 is activated by multimerization and that the levels of intracellular Ca2+ release, reactive oxygen species, and cytokine production correlate with the degree of TREM -1 aggregation, and evidence is provided for ligand-induced, receptor-mediated dimerization of T REM-1.

Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study

TLDR
High levels of circulating Triggering Receptor Expressed on Myeloid cells-1 (TREM-1), were associated with death in acute myocardial infarction confirming excessive inflammation as determinant of bad outcome.

Triggering Receptor Expressed on Myeloid cells-1: a new player in platelet aggregation.

TLDR
It is shown that TREM-1 is constitutively expressed in α-granules and mobilised at the membrane upon platelet activation, suggesting that T REM-1 inhibition could be useful adducts in antiplatelet therapies.

Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis

TLDR
It is reported that TREM-1 potentiates NET release by human and murine neutrophils and is a component of the NET structure, and may constitute a new therapeutic target to prevent NETosis and associated endothelial dysfunction.

References

SHOWING 1-10 OF 32 REFERENCES

Modulation of the Triggering Receptor Expressed on the Myeloid Cell Type 1 Pathway in Murine Septic Shock

TLDR
In septic rats, the TREM-1 peptides improved the hemodynamic status, attenuated the development of lactic acidosis, modulated the production of such proinflammatory cytokines as tumor necrosis factor alpha and interleukin-1β, and improved survival and the protective effect of these peptides on arterial pressure could partly be explained by a decreased production of nitric oxide.

Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats

TLDR
The modulation of the TREM-1 pathway by the means of a synthetic peptide may be useful during acute mesenteric ischemia, and was associated with cardiovascular collapse, lactic acidosis, and systemic and hepatic inflammatory response that were partly prevented by LP17 administration.

Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.

TLDR
It is implied that blockade of TREM-1 could be a new approach to rheumatic diseases that is safer than the presently available immunosuppressive treatments.

Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

TLDR
The modulation of the TREM-1 signaling pathway by the use of small synthetic peptides derived from its extracellular moiety confers interesting survival advantages during experimental murine septic shock and protects from organ damage during other inflammatory diseases.

Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis

TLDR
TREM-1 may act as an important mediator for inflammation and organ injury in SAP and may be a potential therapeutic target for the development of SAP and associated organ dysfunction.

Effects of a TREM-Like Transcript 1–Derived Peptide During Hypodynamic Septic Shock in Pigs

TLDR
Cardiovascular failure was dampened as attested by a better mean arterial pressure, cardiac index, cardiac power index, and SvO2, despite lower norepinephrine requirements.

TREM-1 ligand expression on platelets enhances neutrophil activation.

TLDR
The results indicate that the TREM-1 ligand is expressed by platelets, and the T REM-1/ligand interaction contributes to the amplification of LPS-induced PMN activation.

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

TLDR
A critical function of TREM-1 is demonstrated in acute inflammatory responses to bacteria and it is implicate as a potential therapeutic target for septic shock.

Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis

TLDR
Platelet-derived soluble TLT-1 is identified as a potent endogenous regulator of sepsis-associated inflammation and is anticipated to be important in regulating leukocyte activation during other noninfectious inflammatory disorders.

Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4.

TLDR
It is shown that Lyn, AKT, extracellular signal-regulated kinase 1/2 and Jak2 signaling pathways are elicited following TREM-1 engagement and activation by a monoclonal agonist antibody (anti-TREM- 1) in human PMN, leading to the phosphorylation of STAT5 and RelA, a subunit of the nuclear factor-kappa B family.